Skip to content
NEW: CREATE AN AI-ASSISTED TENDER IN 2 MINUTES — TRY IT FREE
Back to search
GMT – Fertigung

GMP-compliant chemical synthesis of active pharmaceutical ingredients (APIs), specializing in Reduced Folates for oncology and Women's Health.

GMT Logo

GMT Fine Chemicals SA

Couvet (canton of Neuchâtel), SwitzerlandNew on Amplifa

1998Founded
SA (joint-stock company)Legal form
Cerbios-Pharma SA (since September 2011)Majority shareholder
Couvet, canton of NeuchâtelProduction site

About GMT Fine Chemicals SA

GMT Fine Chemicals SA is a Swiss pharmaceutical company founded in 1998 in the industrial area of Couvet in the canton of Neuchâtel, in French-speaking Switzerland. The company specializes in the GMP-compliant chemical synthesis of Active Pharmaceutical Ingredients (APIs), with a focus on Reduced Folates. The production site was designed from the ground up to ensure product quality (GMP), personnel safety, and environmental protection. The portfolio includes Calcium Levofolinate and Calcium Folinate; the therapeutically active substances are primarily used in the manufacture of pharmaceutical medicinal products in the fields of oncology and Women's Health. Swissmedic has granted the company a GMP certificate for the manufacture and distribution of APIs. Since September 2011, Cerbios-Pharma SA has been the majority shareholder of GMT Fine Chemicals SA.

Site
Couvet
Processes
Chemical synthesis of Active Pharmaceutical Ingredients (APIs) under GMP conditions, GMP-compliant chemical synthesis of active ingredients (APIs)
Materials
Calcium Levofolinate, Calcium Folinate
Certificates
GMP certificate (manufacture and distribution of APIs), Accreditation of Foreign Manufacturer, GMP certificate Swissmedic (API manufacture and distribution), PMDA Accreditation of Foreign Manufacturer (Japan), FDA inspection (passed in 2016)
Founded
1998
Industries
Pharmaceutical industry, Oncology, Women's Health
  1. 01

    Chemical synthesis of APIs under GMP conditions

  2. 02

    Quality assurance in accordance with GMP (Swissmedic)

  3. 03

    Distribution of active ingredients

Products & Processes

Ca Levofolinate

Calcium Levofolinate

Reduced Folate as therapeutically active ingredient (API), manufactured under GMP conditions.

Ca Folinate

Calcium Folinate

Reduced Folate as therapeutically active ingredient (API), manufactured under GMP conditions.

Sites

Standort Couvet

Couvet

CH

Production site (chemical synthesis of APIs)

Materials
Calcium Levofolinate, Calcium Folinate

Industries

Pharmaceutical industryOncologyWomen's Health

Processes & technical limits

ProcessesToleranceMax. partWeightLot sizeMaterials
Chemical synthesis of Active Pharmaceutical Ingredients (APIs) under GMP conditionsChemicals/Pharmaceuticals–––––

Additional services

GMP-compliant chemical synthesis of active ingredients (APIs)

Quality & Approvals

Swissmedic has granted GMT Fine Chemicals SA a GMP certificate for the manufacture and distribution of Active Pharmaceutical Ingredients (APIs). The company was successfully inspected by the FDA in 2016 and has been accredited as a Foreign Manufacturer by the Japanese PMDA since 2005.

EvidenceCouvet
GMP certificate Swissmedic (API manufacture and distribution)
PMDA Accreditation of Foreign Manufacturer (Japan)
FDA inspection (passed in 2016)

History

  1. 1998

    Foundation of GMT Fine Chemicals SA in the industrial area of Couvet, canton of Neuchâtel

  2. 2005

  3. 2011

    Cerbios-Pharma SA becomes majority shareholder (September 2011)

  4. 2005

    Accreditation of Foreign Manufacturer from the Japanese PMDA since 2005

  5. 2016

    Successful FDA inspection

Personalised demo

Ready to see Amplifa Marketplace in action?

From a structured request to the right manufacturing partner: AI-assisted matching, verified suppliers and transparent metrics — in one place for industrial companies across the DACH region.

Request a demo